Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Non-surgical treatments can significantly reduce keloids in children, with combination therapies being safer and more effective.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Treatment during development affects hormone balance and sexual behavior in male rats.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Clascoterone 1% cream is a promising new treatment for acne.

Oral and topical anti-androgens can help treat female hair loss, but have side effects.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Medication and hair removal methods can improve hirsutism, but no drugs were specifically approved for it in North America as of 1995.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Spironolactone improved hair density and quality in women with hair loss.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.